Pharmacological mechanisms and therapeutic implications of herbal immunomodulators (mini-review)
Open Access
- 10 April 2026
- journal article
- Published by LLC Information and Research Center Likarska Sprava in Likars'ka Sprava
- No. 2,p. 69–75
Abstract
Introduction. Immunomodulatory medicinal plants have been extensively investigated in vitro, in animal models, and in human studies. Aromatic and essential oil–containing species, including Laurus nobilis, Nigella sativa, Withania somnifera, Echinacea purpurea, and Andrographis paniculata, comprise bioactive phytochemicals such as terpenoids, flavonoids, and phenolic compounds that influence both innate and adaptive immune responses. Aim of the study. This review aimed to provide a translational analysis of mechanistic, preclinical, and clinical evidence supporting their immunomodulatory potential. Methodology. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science, focusing on experimental and human studies reporting immunological outcomes. Discussion. Preclinical investigations demonstrate that plant-derived compounds modulate macrophage activation, cytokine expression, lymphocyte proliferation, and natural killer (NK) cell activity. For example, andrographolide influences T-cell signalling and cytokine production, while thymoquinone enhances NK cell cytotoxicity and regulates Th1/Th2 balance. Translational human studies report increased lymphocyte counts and cytokine levels following supplementation with standardised extracts. Randomised controlled trials further indicate that Withania somnifera enhances immunoglobulins, T helper cells, and NK cell activity. Echinacea purpurea increases NK cytotoxicity and cytokine production, and Allium-based formulations reduce the incidence and severity of respiratory infections in older adults. From a pharmacological perspective, these plants act as multi-target agents modulating signalling cascades and gene expression. However, variability in extract standardisation, dosage regimens, and bioavailability contributes to heterogeneity in clinical outcomes. Conclusion. Overall, medicinal plants demonstrate regulatory rather than purely stimulatory immune effects, supporting their potential role in integrative immunotherapy. Further large-scale, well-controlled trials using standardised preparations are required to strengthen clinical translation.Keywords
This publication has 20 references indexed in Scilit:
- Harnessing the medicinal potential of herbs through hormesis: Perspectives in global health and therapeuticsFood Chemistry Advances, 2025
- Immunomodulatory Effects of Andrographis paniculata Leaf Extract in Cyclophosphamide-induced Immunosuppressed MiceJournal of Pharmacology and Pharmacotherapeutics, 2024
- A randomized, double‐blind, placebo‐controlled study on immune improvement effects of ethanolic extract of Echinacea purpurea (L.) Moench in Korean adultsPhytotherapy Research, 2024
- Enhancing oral bioavailability of andrographolide using solubilizing agents and bioenhancer: comparative pharmacokinetics of Andrographis paniculata formulations in beagle dogsPharmaceutical Biology, 2024
- Immunomodulatory effects of selected medicinal herbs and their essential oils: A comprehensive reviewJournal of Functional Foods, 2022
- Nigella sativa L. as immunomodulator and preventive effect on renal tissue damage of lupus mice induced by pristaneHeliyon, 2022
- Garlic‐Derived Organosulfur Compounds Regulate Metabolic and Immune Pathways in Macrophages and Attenuate Intestinal Inflammation in MiceMolecular Nutrition & Food Research, 2022
- Immunomodulatory effects of Andrographis paniculata extract in healthy adults – An open-label studyJournal of Ayurveda and Integrative Medicine, 2021
- Withania somnifera inhibits NF‐κB and AP‐1 transcription factors in human peripheral blood and synovial fluid mononuclear cellsPhytotherapy Research, 2007
- Botanical immunodrugs: scope and opportunitiesDrug Discovery Today, 2005